FEB 08, 2019 07:51 PM PST

Apsirin Use Prevents Colorectal Cancer

WRITTEN BY: Nouran Amin

In a study published in the American Journal of Medicine, the U.S. Preventive Services Task Force (USPSTF) concluded that aspirin use decreases the risk of colorectal cancer by 40 percent including recurrence of advanced polyps. The study suggested health care providers should prescribe aspirin to all patients with advanced colorectal polyps. "These data indicate underutilization of aspirin to prevent colorectal cancer as well as recurrent polyps in these high risk patients," says Charles H. Hennekens, M.D., Dr.P.H., senior author of the study.

In the United States, colorectal cancer is the third most common cause of cancer deaths with advanced colorectal polyps as a major risk factor. Additional risk factors include inflammatory bowel disease such as Crohn's disease or ulcerative colitis. "More than 90 percent of patients diagnosed with colorectal cancer are 50 years or older. The major risk factors are similar to those for heart attacks and stroke and include overweight, obesity as well as physical inactivity, a diet low in fiber and high in fat as well as type 2 diabetes," said Lawrence Fiedler, M.D., gastroenterologist and affiliate associate professor.

Learn more about colorectal cancer:

"By utilizing these multifactorial approaches, we believe that these efforts should achieve the most good for the most patients concerning the prevention as well as screening and early diagnosis and treatment of colorectal cancers," said Hennekens.

Source: Florida Atlantic University

About the Author
  • Nouran enjoys writing on various topics including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
NOV 18, 2019
Technology
NOV 18, 2019
Computer Model Advances New Therapeutics for Sickle Cell Anemia
A team of Brown University researchers has developed a new computer model that simulates the way red blood cells become misshapen by sickle cell anemia. A ...
NOV 18, 2019
Health & Medicine
NOV 18, 2019
A Skin Patch Might be the Most Effective Melanoma Treatment
Researchers from the Massachusetts Institute of Technology (MIT) have developed a fast-acting skin patch that effectively delivers cancer-fighting medicati...
NOV 18, 2019
Drug Discovery & Development
NOV 18, 2019
Treating Gulf-War Illness with Anti-Viral Drugs
Researchers at the University of South Carolina's Arnold School of Public Health have reported that repurposing existing FDA-approved antiviral drugs o...
NOV 18, 2019
Drug Discovery & Development
NOV 18, 2019
Converting Wood into Pharmaceutical Compounds
Producing toxic byproducts during the making of pharmaceuticals remains a challenge in the drug manufacturing industry. Normally, increased masses of flamm...
NOV 18, 2019
Drug Discovery & Development
NOV 18, 2019
How Fluorescent Probes Can Enhance Drug Delivery
Researchers at Cornell University are working on improving the trial-and-error process that is implicated in finding effective molecules for drug delivery....
NOV 18, 2019
Drug Discovery & Development
NOV 18, 2019
The Side-Effects to A Common Blood Cancer Drug
In a study published in Scientific Reports, a popular cancer drug, known as ruxolitnib, was found to cause an increased weight gain as well as an increase ...
Loading Comments...